LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 151

Search options

  1. Article: Neuromuscular organization of the benthic ctenophore, Vallicula multiformis.

    Mohri, Kurato / Watanabe, Hiroshi

    Zoological letters

    2024  Volume 10, Issue 1, Page(s) 3

    Abstract: Ctenophora is the earliest metazoan taxon with neurons and muscles. Recent studies have described genetic, physiological, and cellular characteristics of the neural and muscular systems of this phylogenically important lineage. However, despite the ... ...

    Abstract Ctenophora is the earliest metazoan taxon with neurons and muscles. Recent studies have described genetic, physiological, and cellular characteristics of the neural and muscular systems of this phylogenically important lineage. However, despite the ecological diversity of ctenophore niches, including both pelagic and benthic forms, studies have focused predominantly on pelagic species. In the present study, we describe the neural and muscular architectures of the benthic ctenophore, Vallicula multiformis (Order Platyctenida), employing immunohistochemical analysis using antibodies against amidated neuropeptides with the C-terminal sequences VWYa, NPWa, FGLa, or WTGa to compare it to pelagic species. In V. multiformis, which lacks the characteristic comb rows seen in pelagic ctenophores, neural structures that develop beneath the comb were not detected, whereas the subepithelial and tentacle neural networks showed considerable similarity to those of pelagic species. Despite significant differences in morphology and lifestyle, muscle organization in V. multiformis closely resembles that of pelagic species. Detailed analysis of neurons that express these peptides unveiled a neural architecture composed of various neural subtypes. This included widely distributed subepithelial neural networks (SNNs) and neurosecretory cells located primarily in the peripheral region. The consistent distribution patterns of the VWYa-positive SNN and tentacle nerves between V. multiformis and the pelagic species, Bolinopsis mikado, suggest evolutionarily conserved function of these neurons in the Ctenophora. In contrast, NPWa-positive neurons, which extend neurites connecting the apical organ and comb rows in B. mikado, showed a neurite-less neurosecretory cell morphology in this flattened, sessile species. Evaluation of characteristics and variations in neural and muscular architectures shared by benthic and pelagic ctenophore species may yield valuable insights for unraveling the biology of this rapidly evolving yet enigmatic metazoan lineage. These findings also provide important insight into neural control modalities in early metazoan evolution.
    Language English
    Publishing date 2024-01-30
    Publishing country England
    Document type Journal Article
    ZDB-ID 2809936-9
    ISSN 2056-306X
    ISSN 2056-306X
    DOI 10.1186/s40851-024-00225-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Investigating effective methods of clinical pharmacy training on oncology for community pharmacists: An observational study.

    Fukawa, Takahiro / Mohri, Junichi / Inano, Hiroshi / Atsuda, Koichiro / Otori, Katsuya

    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

    2023  , Page(s) 10781552231200427

    Abstract: Introduction: Kitasato University Hospital offers a training course for community pharmacists that focus on advanced pharmacy management care in outpatient cancer chemotherapy. The objective of this training program is to facilitate the transition from ... ...

    Abstract Introduction: Kitasato University Hospital offers a training course for community pharmacists that focus on advanced pharmacy management care in outpatient cancer chemotherapy. The objective of this training program is to facilitate the transition from general to oncology certification for community pharmacists with limited experience in outpatient oncology to support the acquisition of an oncology specialty.
    Aim: To evaluate the relationship between the changes in awareness, knowledge, and self-assessment that advanced pharmacy management care traineeship in an outpatient oncology unit for community pharmacists brings to trainees and the duration of training.
    Methods: A quantitative text analysis was conducted of the daily training reports of six community pharmacists who had participated previously in the training course and had received in-service training in oncology for at least 30 days. The pre- and post-training results of the knowledge tests and self-assessments of confidence, understanding, and performance were compared. This study was approved by the Research Ethics Committee of Kitasato Institute Hospital in October 2019 (Study No. 19044).
    Results: The terms
    Conclusions: Community pharmacists with limited experience in outpatient oncology could improve their knowledge, understanding, and awareness of outpatient oncology patient care through 30 days of in-service oncology training in a hospital setting. The issues that emerged included training pharmacists to send follow-up documents on the patients' side effects and medication status as well as developing the literature search environment in community pharmacies.
    Language English
    Publishing date 2023-09-12
    Publishing country England
    Document type Journal Article
    ZDB-ID 1330764-2
    ISSN 1477-092X ; 1078-1552
    ISSN (online) 1477-092X
    ISSN 1078-1552
    DOI 10.1177/10781552231200427
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Impaired potency of neutralizing antibodies against cell-cell fusion mediated by SARS-CoV-2.

    Wang, Qian / Yeh, Andre Yanchen / Guo, Yicheng / Mohri, Hiroshi / Yu, Jian / Ho, David D / Liu, Lihong

    Emerging microbes & infections

    2023  Volume 12, Issue 1, Page(s) 2210237

    Abstract: The SARS-CoV-2 Omicron subvariants have dominated the pandemic due to their high transmissibility and immune evasion conferred by the spike mutations. The Omicron subvariants can spread by cell-free virus infection and cell-cell fusion, the latter of ... ...

    Abstract The SARS-CoV-2 Omicron subvariants have dominated the pandemic due to their high transmissibility and immune evasion conferred by the spike mutations. The Omicron subvariants can spread by cell-free virus infection and cell-cell fusion, the latter of which is more effective but has not been extensively investigated. In this study, we developed a simple and high-throughput assay that provides a rapid readout to quantify cell-cell fusion mediated by the SARS-CoV-2 spike proteins without using live or pseudotyped virus. This assay can be used to identify variants of concern and to screen for prophylactic and therapeutic agents. We further evaluated a panel of monoclonal antibodies (mAbs) and vaccinee sera against D614G and Omicron subvariants, finding that cell-cell fusion is substantially more resistant to mAb and serum inhibition than cell-free virus infection. Such results have important implications for the development of vaccines and antiviral antibody drugs against cell-cell fusion induced by SARS-CoV-2 spikes.
    MeSH term(s) Humans ; Antibodies, Neutralizing ; Cell Fusion ; SARS-CoV-2 ; COVID-19 ; Antibodies, Viral ; Antibodies, Monoclonal/pharmacology ; Antiviral Agents ; Spike Glycoprotein, Coronavirus/genetics
    Chemical Substances Antibodies, Neutralizing ; Antibodies, Viral ; Antibodies, Monoclonal ; Antiviral Agents ; Spike Glycoprotein, Coronavirus ; spike protein, SARS-CoV-2
    Language English
    Publishing date 2023-05-02
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2681359-2
    ISSN 2222-1751 ; 2222-1751
    ISSN (online) 2222-1751
    ISSN 2222-1751
    DOI 10.1080/22221751.2023.2210237
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Antibody neutralisation of emerging SARS-CoV-2 subvariants: EG.5.1 and XBC.1.6.

    Wang, Qian / Guo, Yicheng / Zhang, Richard M / Ho, Jerren / Mohri, Hiroshi / Valdez, Riccardo / Manthei, David M / Gordon, Aubree / Liu, Lihong / Ho, David D

    The Lancet. Infectious diseases

    2023  Volume 23, Issue 10, Page(s) e397–e398

    MeSH term(s) Humans ; SARS-CoV-2 ; COVID-19 ; Immunoglobulins ; Antibodies, Viral ; Antibodies, Neutralizing/therapeutic use
    Chemical Substances Immunoglobulins ; Antibodies, Viral ; Antibodies, Neutralizing
    Language English
    Publishing date 2023-09-11
    Publishing country United States
    Document type Letter
    ZDB-ID 2061641-7
    ISSN 1474-4457 ; 1473-3099
    ISSN (online) 1474-4457
    ISSN 1473-3099
    DOI 10.1016/S1473-3099(23)00555-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Rebound of SARS-CoV-2 Infection after Nirmatrelvir-Ritonavir Treatment.

    Charness, Michael E / Gupta, Kalpana / Stack, Gary / Strymish, Judith / Adams, Eleanor / Lindy, David C / Mohri, Hiroshi / Ho, David D

    The New England journal of medicine

    2022  Volume 387, Issue 11, Page(s) 1045–1047

    MeSH term(s) Antiviral Agents/adverse effects ; Antiviral Agents/therapeutic use ; Drug Combinations ; Humans ; Lactams/adverse effects ; Lactams/therapeutic use ; Leucine/adverse effects ; Leucine/therapeutic use ; Nitriles/adverse effects ; Nitriles/therapeutic use ; Proline/adverse effects ; Proline/therapeutic use ; Recurrence ; Ritonavir/adverse effects ; Ritonavir/therapeutic use ; SARS-CoV-2 ; COVID-19 Drug Treatment
    Chemical Substances Antiviral Agents ; Drug Combinations ; Lactams ; Nitriles ; nirmatrelvir and ritonavir drug combination ; Proline (9DLQ4CIU6V) ; Leucine (GMW67QNF9C) ; Ritonavir (O3J8G9O825)
    Language English
    Publishing date 2022-09-07
    Publishing country United States
    Document type Letter
    ZDB-ID 207154-x
    ISSN 1533-4406 ; 0028-4793
    ISSN (online) 1533-4406
    ISSN 0028-4793
    DOI 10.1056/NEJMc2206449
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Molnupiravir maintains antiviral activity against SARS-CoV-2 variants and exhibits a high barrier to the development of resistance.

    Strizki, Julie M / Gaspar, John M / Howe, John A / Hutchins, Beth / Mohri, Hiroshi / Nair, Manoj S / Kinek, Keith C / McKenna, Philip / Goh, Shih Lin / Murgolo, Nicholas

    Antimicrobial agents and chemotherapy

    2023  Volume 68, Issue 1, Page(s) e0095323

    Abstract: Molnupiravir, an oral prodrug of N-hydroxycytidine (NHC), previously demonstrated ... ...

    Abstract Molnupiravir, an oral prodrug of N-hydroxycytidine (NHC), previously demonstrated broad
    MeSH term(s) Humans ; SARS-CoV-2/genetics ; COVID-19 ; Antiviral Agents/pharmacology
    Chemical Substances molnupiravir (YA84KI1VEW) ; Antiviral Agents
    Language English
    Publishing date 2023-12-04
    Publishing country United States
    Document type Journal Article
    ZDB-ID 217602-6
    ISSN 1098-6596 ; 0066-4804
    ISSN (online) 1098-6596
    ISSN 0066-4804
    DOI 10.1128/aac.00953-23
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Ad26.COV2.S boosts antibody and T-cell responses following BNT162b2 vaccination.

    Iketani, Sho / Liu, Lihong / Nair, Manoj S / Chandrashekar, Abishek / Mohri, Hiroshi / Wang, Maple / Barouch, Dan H / Huang, Yaoxing / Ho, David D

    Emerging microbes & infections

    2021  Volume 10, Issue 1, Page(s) 2220–2222

    MeSH term(s) Ad26COVS1/administration & dosage ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/immunology ; BNT162 Vaccine/administration & dosage ; COVID-19/immunology ; COVID-19/prevention & control ; COVID-19/virology ; Humans ; SARS-CoV-2/genetics ; SARS-CoV-2/immunology ; T-Lymphocytes/immunology ; Vaccination
    Chemical Substances Ad26COVS1 (JT2NS6183B) ; Antibodies, Neutralizing ; Antibodies, Viral ; BNT162 Vaccine (N38TVC63NU)
    Language English
    Publishing date 2021-11-12
    Publishing country United States
    Document type Letter
    ZDB-ID 2681359-2
    ISSN 2222-1751 ; 2222-1751
    ISSN (online) 2222-1751
    ISSN 2222-1751
    DOI 10.1080/22221751.2021.2006581
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Correction to: Preparation of Controlled-Release Particles Based on Spherical Porous Silica Used as the Drug Carrier by the Dry Coating Method.

    Nakamura, Shohei / Kondo, Shihoko / Mohri, Ayaka / Sakamoto, Takatoshi / Yuasa, Hiroshi

    AAPS PharmSciTech

    2018  Volume 19, Issue 7, Page(s) 3323

    Abstract: In the present notation, the formula names and the formulas (page 7, left column, lines 20-21) do not correspond to each other. It is a completely incorrect description, due to a typesetting mistake by the publisher. See below for details. The original ... ...

    Abstract In the present notation, the formula names and the formulas (page 7, left column, lines 20-21) do not correspond to each other. It is a completely incorrect description, due to a typesetting mistake by the publisher. See below for details. The original article has been corrected.
    Language English
    Publishing date 2018-02-23
    Publishing country United States
    Document type Journal Article ; Published Erratum
    ISSN 1530-9932
    ISSN (online) 1530-9932
    DOI 10.1208/s12249-018-0981-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Drug Resistance Mutation Frequency of Single-Genome Amplification-Derived HIV-1 Polymerase Genomes in the Cerebrospinal Fluid and Plasma of HIV-1-Infected Individuals under Nonsuppressive Therapy.

    St Bernard, Leslie / Abolade, Jeremy / Mohri, Hiroshi / Markowitz, Martin / Evering, Teresa H

    Journal of virology

    2020  Volume 94, Issue 20

    Abstract: HIV-1 evolution in the cerebrospinal fluid (CSF) and plasma may result in discordant drug resistance mutations (DRMs) in the compartments. Single-genome amplification (SGA) was used to generate partial HIV-1 polymerase genomes in paired CSF and plasma ... ...

    Abstract HIV-1 evolution in the cerebrospinal fluid (CSF) and plasma may result in discordant drug resistance mutations (DRMs) in the compartments. Single-genome amplification (SGA) was used to generate partial HIV-1 polymerase genomes in paired CSF and plasma samples from 12 HIV-1-positive participants in the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) study who were classified as neurocognitively unimpaired or with various degrees of HIV-associated neurocognitive disorders (HAND). Subjects were viremic on combination antiretroviral therapy (cART). HIV-1 DRMs and phylogenetic characteristics were determined using the Stanford HIVdb program and phylogenetic analyses. Individual DRMs were identified more frequently in plasma than in paired CSF (
    MeSH term(s) Adult ; Anti-Retroviral Agents/administration & dosage ; Drug Resistance, Viral ; Female ; Genome, Viral ; HIV Infections/blood ; HIV Infections/cerebrospinal fluid ; HIV Infections/drug therapy ; HIV Infections/genetics ; HIV-1/genetics ; HIV-1/metabolism ; Humans ; Male ; Middle Aged ; Mutation Rate
    Chemical Substances Anti-Retroviral Agents
    Language English
    Publishing date 2020-09-29
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 80174-4
    ISSN 1098-5514 ; 0022-538X
    ISSN (online) 1098-5514
    ISSN 0022-538X
    DOI 10.1128/JVI.01824-19
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Acquired von Willebrand syndrome: features and management.

    Mohri, Hiroshi

    American journal of hematology

    2006  Volume 81, Issue 8, Page(s) 616–623

    Abstract: Acquired von Willebrand syndrome (AvWS) is not a well-known bleeding disorder among clinicians and is associated with various underlying diseases. The clinical manifestations are similar to congenital von Willebrand disease. Diagnosis is confirmed mainly ...

    Abstract Acquired von Willebrand syndrome (AvWS) is not a well-known bleeding disorder among clinicians and is associated with various underlying diseases. The clinical manifestations are similar to congenital von Willebrand disease. Diagnosis is confirmed mainly by a decrease of ristocetin cofactor activity (vWF:RCo) and/or collagen binding activity (vWF:CBA) and by vWF multimeric analysis, usually with a selective loss of large multimers. Plasma von Willebrand factor propeptide (vWF:AgII) is a good marker of vWF synthesis. Various pathogenic mechanisms have been proposed, including development of autoantibodies to the von Willebrand factor (vWF), adsorption of vWF onto tumor cells or activated platelets, increase of vWF proteolysis, and mechanical destruction of vWF under high shear stress. Treatment of the underlying disorder may resolve AvWS. Desmopressin (DDAVP) is a first-line therapeutic option. Factor VIII/vWF concentrates and high-dose immunoglobulin infusions are reserved for patients unresponsive to DDAVP.
    MeSH term(s) Deamino Arginine Vasopressin/therapeutic use ; Factor VIII/therapeutic use ; Humans ; Immunoglobulins, Intravenous/therapeutic use ; von Willebrand Diseases/diagnosis ; von Willebrand Diseases/etiology ; von Willebrand Diseases/therapy
    Chemical Substances Immunoglobulins, Intravenous ; Factor VIII (9001-27-8) ; Deamino Arginine Vasopressin (ENR1LLB0FP)
    Language English
    Publishing date 2006-08
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 196767-8
    ISSN 1096-8652 ; 0361-8609
    ISSN (online) 1096-8652
    ISSN 0361-8609
    DOI 10.1002/ajh.20455
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top